Other languages Mangoceuticals, Inc.

Equities

MGRX

US56270V1061

Real-time Estimate Cboe BZX Other stock markets 12:48:31 2024-06-04 pm EDT			5-day change	1st Jan Change
0.375 ^USD	+7.14%		-13.64%	+37.23%

02:00pm	Mangorx to Introduce ?Mojo? Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances	CI
May. 21	Sector Update: Health Care Stocks Advance Late Afternoon	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Advance Late Afternoon	May. 21
Sector Update: Health Care	May. 21
Top Midday Gainers	May. 21
Mangoceuticals, Inc. to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications	May. 21
Mangoceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15
Mangoceuticals Signs Securities Purchase Deal; Mexican Unit Enters Technical Deal With Emifarma	Apr. 12
Top Premarket Gainers	Mar. 20
Mangoceuticals, Inc. Officially Launches ?PRIME? by MangoRx, Powered by Kyzatrex® FDA Approved Oral Testosterone Replacement Therapy Treatment	Mar. 12
Mangoceuticals, Inc. Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth	Feb. 20
Mangoceuticals, Inc. Accepting Pre Orders for its PRIME	Feb. 05
Wall Street Set to Open Narrowly Mixed Ahead of PMI, Industrial Production Data	Dec. 15
Investors Look to Keep Rally Going as US Futures Trend Higher Friday	Dec. 15
Top Premarket Decliners	Dec. 15
Mangoceuticals, Inc. to Introduce ?Prime?, Powered by Kyzatrex® (Ciii Testosterone Undecanoate Capsules), for an FDA Approved Oral Testosterone Replacement Therapy Product	Dec. 13
Mangoceuticals Expands its Men's Health Product Line with Compounded Hair Growth Treatment 'Grow' by MangoRx	Nov. 16
Wall Street Set to Open Slightly Higher; Weekly Jobless Claims Fall to Near Historic Lows	23-10-19
Top Premarket Gainers	23-10-19
Mangoceuticals, Inc. Launches New Sildenafil Based Erectile Dysfunction Product with Signature Mango Flavor & Rapid Dissolve	23-08-16
Mangoceuticals Partners With Greater NY Chamber of Commerce for Marketing Mango Drug Product	23-08-09
Mangoceuticals Shares Rise Following Announcement of Collaboration With RedLime Solutions	23-08-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Mangoceuticals, Inc.

Equities

MGRX

US56270V1061

Other languages

Filters